ALLODX
Non-invasive Transplant Injury Monitoring
Focusing on different transplant scenarios, non-invasive damage monitoring and related testing data are collected.
AlloK kidney transplant
For information on non-invasive rejection and infection detection of kidney transplantation, please see the introduction to Allok Seq® and BKVAN detection.
Allok Seq® Full Set of Non-Invasive Rejection and Infection Testing for Kidney Transplantation
AlloDx AllokSeq® Ankang·Kidney Transplantation Non-invasive Rejection and Infection Complete Test, by monitoring the free DNA content of the transplanted kidney, evaluates the health status of the transplanted kidney, and can be used for rejection monitoring, BK virus-related nephropathy (BKVAN) monitoring and pathogenic microbial infection monitoring, and can...
Read more ↗Non-invasive test for BK virus-associated nephropathy (BKVAN)
BK virus-associated nephropathy (BKVAN) testing protocol, testing principle, and applicable groups
Read more ↗lung transplant
Non-invasive lung transplant rejection related detection.
heart transplant
Non-invasive rejection-related detection of heart transplantation.
Other transplant monitoring
xenotransplantation
Communicate the testing plan around the research purpose, samples, and monitoring indicators of xenotransplantation. Please contact the technical team to confirm the specific project scope.
Testing data related to liver transplantation and graft-versus-host disease.
Non-invasive liver transplant rejection testing
Cell free DNA (cfDNA) refers to free and extracellular DNA fragments from cell apoptosis or necrosis. Patient plasma contains cfDNA derived from apoptosis of donor tissue cells. A large amount of research and experimental data show that cfDNA is a new indicator of migration...
Read more ↗Liver cancer liver transplant recurrence detection
The recurrence rate of liver cancer can reach 20%~57.8% 5 years after liver transplantation. The application of calcineurin inhibitor (CNI) is an independent risk factor for liver cancer recurrence after liver transplantation. When the recipient is in a strong immunosuppression state, the immune monitoring system...
Read more ↗GVHD detection after liver transplantation
Graft versus host disease (GVHD) detection after liver transplantation Graft versus host disease (GVHD) is a rare complication after liver transplantation, with an incidence rate of <1% and a very high mortality rate of about 85%. GVHD is…
Read more ↗Early screening for graft-versus-host disease
Graft versus host disease (GvHD) is tissue damage caused by donor-derived immune cells reconstituted in the patient’s body after hematopoietic stem cell transplantation (HSCT) attacking the recipient’s organs. It is a serious post-transplantation complication that occurs…
Read more ↗Discuss Your Project
Please confirm with the AlloDx technical team for sample requirements, testing scope, project cycle and report content.
Contact AlloDx ↗